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COMPARISON OF FACTOR VIII ACTIVITY IN O AND NON-O BLOOD 
TYPES 
(Perbandingan Aktivitas Faktor VIII antara Golongan Darah O dan Non-O)
Adil Dinata Simangunsong, Yetti Hernaningsih
ABSTRAK
Golongan darah ABO telah dinilai untuk terjadinya berbagai proses penyakit. Penelitian terdahulu menyatakan tingginya 
kejadian trombosis pada golongan darah non O disebabkan tingginya aktivitas faktor VIII dibandingkan golongan darah O. Metode 
penelitian merupakan analitik observasional secara potong lintang. Sampel darah sitrat dengan nilai APTT dan PTT normal tanpa 
mempertimbangkan usia, jenis kelamin dan diagnosis. Aktivitas factor VIII diperiksa menggunakan sysmex CS 2100i. Analisis statistik 
mengunakan one way Anova untuk golongan darah A, B, O dan uji sampel T independen untuk golongan darah O dan non-O. Dari 
keseluruhan 30 sampel didapatkan 15 sampel golongan darah non-O dan 15 sampel golongan darah O. Pada golongan darah non-O 
didapatkan 8 sampel golongan darah A dan 7 sampel golongan darah B. Terdapat perbedaan aktivitas faktor VIII yang tidak bermakna 
antara golongan darah non-O dan O (p=0,277). Pada golongan darah A, B, O, juga didapatkan perbedaan yang tidak bermakna 
(p=0,108). Aktivitas faktor VIII pada golongan darah non-O lebih tinggi dibandingkan golongan darah O, tetapi tidak didapatkan 
perbedaan bermakna. Pada golongan darah A,B,O juga tidak didapatkan perbedaan bermakna. Mekanisme yang mendasari hubungan 
antara golongan darah ABO dengan aktivitas faktor VIII sampai sekarang belum diketahui. Tidak didapatkan perbedaan bermakna 
aktivitas faktor VIII antara golongan darah O dan non-O. Diperlukan penelitian dengan jumlah sampel yang lebih banyak dan mengikut 
sertakan golongan darah AB.
Kata kunci: Aktivitas faktor VIII, golongan darah ABO, PPT dan APT
ABSTRACT
ABO blood types have been evaluated for the occurrence of a variety of disease processes. Previous studies have claimed that 
the high incidence of thrombosis in non-O blood types is due to the high activity of factor-VIII compared O blood type. This study 
was an observational cross-sectional analytical. The samples consisted of citrate blood with normal APTT and PTT values without 
considering age, sex and diagnosis. Factor VIII activity was examined using Sysmex CS 2100i. Statistical analysis used an one-way 
ANOVA for A, B, O blood types and independent sample t test for O and non-O blood types. Results from the total 30 samples, 15 
samples had non-O blood type and 15 samples of O blood type. In non-O blood type there were eight samples with A blood type 
and seven samples with B blood type. It was shown that the difference of factor VIII activity was not significant among non-O and O 
blood types (p=0.277). A, B, O blood types also showed no significant difference (p=0.108). Conclusion, there were no significant 
differences between factor VIII activity in O and non-O blood types. Studies with a larger sample size and involving blood type AB 
are needed.
Key words: Factor VIII activity, ABO blood types, PPT and APT
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INTRODUCTION
Factor-VIII (anti-hemophilia factor) is a glycoprotein 
cofactor which serves as an essential component of 
the intrinsic pathway. Factor-VIII deficiency results 
in hemophilia A disease. Factor-VIII is a multidomain 
glycoprotein with domain structure A1-A2-B-A3-C1-
C2, in which the heavy chain consists of A1-A2-B and 
the light chain A3-C1-C2.1 Many studies linked ABO 
blood types with a variety of disease processes.2,3
ABO blood types has a functional effect on factor-
VIII. Individuals with non-O blood type have higher 
levels of factor VIII than those with O blood type. 
Factor VIII is 25–30% lower in O blood type. Factor 
VIII activity does not differ significantly between A, 
B and AB, blood types although it is generally higher 
in AB blood types.4–9 Several previous studies have 
demonstrated that factor VIII activity is influenced by 
age, sex and blood types in healthy people. According 
to Cooperber & Teitelbaum, factor-VIII is higher in 
the elderly and in males. Pitney et al.4 stated that 
factor-VIII is higher in the elderly and not influenced 
by gender. Preston & Barr5 stated that the effect of 
age is not significant, but it is higher in males than 
females.4,5
In normal subjects, the activity of factor-VIII 
ranges from 50–150%.7 High factor-VIII can be 
caused by stress, pregnancy, atherosclerosis, obesity, 
high triglyceride levels and acute phase response 
(malignancy and chronic inflammation). Some 
previous studies have claimed that non-O blood types 
have the risk of thrombosis and O blood type with 
the risk of hemorrhage.4,6,8,10-12 Factor-VIII is an acute 
phase protein and is increased temporarily during an 
inflammatory process. Kamphuisen’s study showed 
no relationship between factor VIII activity and CRP 
(C-Reactive Protein) in venous thrombosis patients. 
They also revealed that high activity of factor-VIII 
settles until several months after the occurrence of 
venous thrombosis. These results are consistent with a 
study by O’Donnell.13-15 
Several studies have demonstrated that a high 
activity of factor VIII is persistent and serves as a 
risk factor for thrombosis, but it has not been known 
how much the cut-off value is of factor-VIII that leads 
to thrombosis.4 The Genetic Analysis of Idiopathic 
Thrombophilia (GAIT) study found a relationship 
between factor VIII activity with a Activated Protein 
C resistance  in the pathogenesis of thrombosis. 
Activated Protein C resistance increases the risk of 
venous thrombotic events.13,14 High factor-VIII with 
the possibility of thrombosis is associated with a 
genetic disorder, that is the presence of the locus on 
chromosome 18,4,13,14
This study was conducted to determine whether 
factor VIII activity in non-O blood type was higher 
than that in O blood type and factor VIII activity in 
the A, B and O blood types using Sysmex CS-2100i. In 
addition, the authors also wanted to find out the cause 
of high-factor VIII activity in O blood type compared 
to that of non-O, which is still controversial. This study 
aimed to determine whether there were differences in 
factor-VIII activity in O and non-O blood type. 
METHODS
This study was an observational analytic cross-
sectional study. The study was conducted November 
2014 at the Clinical Pathology Laboratory, Dr. Soetomo 
Hospital. The inclusion criteria were blood samples in 
citrate tubes with normal results of APTT and PPT, 
regardless of age, sex and diagnosis of disease. Sample 
size in this study was 30 samples. The samples were 
venous blood in tubes containing 3.2% sodium citrate 
and citrate blood with a ratio of 9: 1. A total of 30 
samples with normal APTT and PPT were selected 
and blood type examination was done, yielding in 15 
non-O blood type (8 A blood type and 7 B blood type) 
and 15 O blood type. 
Examination of factor VIII activity was carried out 
on each blood type. The samples were divided into 2 
groups. Group 1 comprised samples of A, B, O blood 
types and group 2 O and non-O blood type. APTT, 
PPT and-factor VIII activity examination was done by 
the method of photo optical using Sysmex CS-2100i. 
Statistical analysis used SPSS 13. 
Data were analyzed using one way Anova 
comparative test for A, B, O blood types and 
independent sample t test for O and non-O blood types, 
with a significance level of p<0.005 was considered 
statistically significant and the confidence level was 
95%.
RESULTS AND DISCCUSION
Data normality test of factor VIII in blood types A, 
B and O shows that all data had a normal distribution, 
so to test the difference of factor VIII in A, B and O 
blood types one way ANOVA as used (Table 1).
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One Way ANOVA test results on the data of factor 
VIII activity in A, B and O blood types revealed 
p=0.108. This result indicated that there was no 
difference in factor VIII activity between A, B and O 
blood types.
Normality test of factor VIII activity in O and 
non-O blood types showed that both had a normal 
distribution, so to examine differences in the factor-VIII 
activity in O and non-O blood types used independent 
sample t test (Table 2).
The result of independent sample t test on factor 
VIII activity in O and non-O blood types revealed 
p=0.277. This result indicated that there was no 
difference in factor-VIII activity in O and non-O blood 
types.
Factor-VIII activities in A, B, O blood types showed 
no difference (p=0.108). The highest factor VIII 
activities were found in A blood type (mean=149.8; 
±SD=17.6), followed by O blood type (mean=128.2%; 
±SD=13.3) and B blood type (mean=127.6; 
±SD=13.3). A study by Preston & Barr7 stated that 
there were significant differences in factor VIII 
activity, in which the A blood type and B is higher 
than O. While non-O and O blood type also showed 
no significant difference (p=0.277) in factor VIII 
activity in non-O (mean=138.0%; ±SD=31.2) and 
O (mean=128.2%; ±SD=13.3) blood types. Some 
previous studies also revealed no significant difference 
between non-O and O blood types.7
Differences in blood type phenotypes are partially 
dependent on the race. In Caucasians A1=33%, 
A2=10%, B=9%, A1B=3%, A2B=1%, Asian A1=27%, 
A2=rarely, B=25%, A1B=5%, A2B=rarely and African 
A1=19%, A2=8%, B=20%, A1B=3%, A2B=1%. O 
blood type is found in most wide populations.11 A 
recent study found that phenotypic factors were 
associated with a high risk of venous thrombosis.15 
This study did not obtain the AB blood type samples. 
It may be caused from rare population of individuals 
with AB blood type, similar to the a previous study of 
Preston & Barr.7
Factor VIII activity and non-O blood type are 
independent risk factors for venous thromboembolism. 
Allegedly, A1 allele gene also plays a role in the 
occurrence of thromboembolic. Several previous 
studies found that factor VIII contributes to the 
occurrence of thrombosis, according to Kraaijenhagen 
et al. and Kyrle et al.4
The high activity of factor VIII is related to 
prothrombotic hyperactivity in arterial and venous 
systems. According to Vormittag, factor VIII activity of 
>232% is an independent risk factor for the incidence 
of thromboembolic complications. Kamphuisen stated 
that only 4% of factor VIII activity >123% may cause 
the incidence of arterial thrombosis.13 High factor-
VIII activity is the risk factor of thrombosis, with a 
greater impact on venous thrombosis than arterial 
thrombosis.15 In this study, factor VIII activity between 
O and non-O blood types was not significantly 
different.
Limitation of this study were that age, sex and 
diagnosis of disease were not consider. The samples 
were studied only in A, B and O blood types with 
normal APTT and PPT values. Previous studies found 
that factor VIII activity was not affected by age, gender 
and diagnosis of disease. Some studies also suggested 
Table 1.  Results analysis of comparative test of factor VIII activity in A, B and O blood types 
Blood types
Factor VIII activity
P value
Min Max Mean SD
A 128.8 175.1 149.8 17.6
0.108B 68.2 178.5 127.6 37.7
O 105.8 151.4 128.2 13.3
Table 2. Results analysis of comparative test on factor VIII activity in O and non-O blood types 
Blood types
Faktor VIII Activity
P values
Min Max Mean SD
Non O 68.2 178.5 138.0 31.2
0.277
O 105.8 151.4 128.2 13.3
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that high factor VIII activity was affected by pregnancy, 
surgical intervention, the use of birth control pills, 
diabetes mellitus, renal failure and malignant disease.5 
The mechanism of genetic and environmental factors, 
that leads to a high factor VIII activity, as the cause of 
thrombosis, is not yet fully known.13–15
CONCLUSION AND SUGGESTION
No significant differences were present in factor 
VIII activity between A, B and O blood types. Further 
research is needed with a larger number of samples 
and including AB blood type.
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